Deniz Kilic1, Derya Kocer2, Ender Sırakaya3, Bekir Küçük3, Esra Vural3, Soner Guven3, Necati Duru3. 1. Department of Ophthalmology, Kayseri City Training and Research Hospital, Health Science University, Yakut Region, 3844 Street, House Number: 20/16, 38001, Kayseri, Turkey. dnz_kilic@hotmail.com. 2. Department of Biochemistry, Kayseri City Training and Research Hospital, Health Science University, Kayseri, Turkey. 3. Department of Ophthalmology, Kayseri City Training and Research Hospital, Health Science University, Yakut Region, 3844 Street, House Number: 20/16, 38001, Kayseri, Turkey.
Abstract
PURPOSE: To evaluate whether the systemic oxidative stress biomarkers increased in patients with vitreomacular traction syndrome (VMT). METHODS: This study compared 25 patients diagnosed with VMT with 20 healthy controls. As a biomarker of systemic oxidative stress, malondialdehyde (MDA) was measured. Total oxidant status (TOS) and total antioxidant status (TAS) were measured to evaluate the systemic oxidant status. RESULTS: Serum MDA values were significantly higher among the patients (p < 0.001). The ideal cut-off value for MDA was determined to be 22.1 µmol/L, with 80% sensitivity and 75% specificity. The between-group differences were not statistically significant for TOS or TAS (p = 0.326 and p = 0.698, respectively). CONCLUSION: Increased MDA levels suggest that systemic oxidative stress may play a role in VMT.
PURPOSE: To evaluate whether the systemic oxidative stress biomarkers increased in patients with vitreomacular traction syndrome (VMT). METHODS: This study compared 25 patients diagnosed with VMT with 20 healthy controls. As a biomarker of systemic oxidative stress, malondialdehyde (MDA) was measured. Total oxidant status (TOS) and total antioxidant status (TAS) were measured to evaluate the systemic oxidant status. RESULTS: Serum MDA values were significantly higher among the patients (p < 0.001). The ideal cut-off value for MDA was determined to be 22.1 µmol/L, with 80% sensitivity and 75% specificity. The between-group differences were not statistically significant for TOS or TAS (p = 0.326 and p = 0.698, respectively). CONCLUSION: Increased MDA levels suggest that systemic oxidative stress may play a role in VMT.
Authors: Katherine J Wert; Gabriel Velez; Madeline R Cross; Brett A Wagner; Melissa L Teoh-Fitzgerald; Garry R Buettner; J Jason McAnany; Alicia Olivier; Stephen H Tsang; Matthew M Harper; Frederick E Domann; Alexander G Bassuk; Vinit B Mahajan Journal: Free Radic Biol Med Date: 2018-06-22 Impact factor: 7.376
Authors: Stacy M Meuer; Chelsea E Myers; Barbara E K Klein; Maria K Swift; Yijun Huang; Sapna Gangaputra; Jeong W Pak; Ronald P Danis; Ronald Klein Journal: Ophthalmology Date: 2014-12-31 Impact factor: 12.079
Authors: Christina J Flaxel; Ron A Adelman; Steven T Bailey; Amani Fawzi; Jennifer I Lim; G Atma Vemulakonda; Gui-Shuang Ying Journal: Ophthalmology Date: 2019-09-25 Impact factor: 12.079